RNXT CIK: 1574094

RenovoRx, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.92
FY22:
−8.81
FY23:
−10.3
FY24:
−9.13
FY25:
−11.0
Change from FY21 to FY25
millions USD
FY21:
−0.02
FY22:
−2.03
FY23:
2.03
FY24:
−0.01
FY25:
0.00
Change from FY21 to FY25
millions USD
FY21:
19.3
FY22:
0.04
FY23:
5.01
FY24:
15.1
FY25:
10.8
millions USD
FY21:
13.4
FY22:
−10.8
FY23:
−3.22
FY24:
5.98
FY25:
−0.13
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−9.14
FY25:
−11.0

All amounts in millions USD Data source:SEC EDGAR